StockData
Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd

TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$41.31−0.19 (-0.46%)

Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –

Teva Pharmaceutical Industries Manufacturing & R&D Floor Area — United States by Year

Manufacturing & R&D Floor Area — United States (K sq ft)

Teva Pharmaceutical Industries Manufacturing & R&D Floor Area — United States: 1,891.0K sq ft in FY2025, down 43.4% from a year earlier.

Latest, FY2025
1,891.0
Period ended Dec 31, 2025
Change on a year earlier
-43.4%
3,340.0 in FY2024
History
3 years
Since FY2017
Sources
3
Documents cited below

Where the FY2025 figure comes from

“|| United States | 10 | 1,891”

Source: Form 10-K (0001193125-26-034532) ↗

Reported in SEC Form 10-K (Item 2. Properties).

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedManufacturing & R&D Floor Area — United States (K sq ft)Year on yearSource
FY2025Dec 31, 20251,891.0-43.4%Form 10-K (0001193125-26-034532) ↗
FY2024Dec 31, 20243,340.0–Form 10-K (0001193125-25-020826) ↗
FY2017Dec 31, 20172,758.0–Form 10-K (0001193125-18-039076) ↗

Cite this data

StockData. (2026). Teva Pharmaceutical Industries Manufacturing & R&D Floor Area — United States (K sq ft), annual FY2017–FY2025 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/fac-us-sqft

See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.

See a number that looks wrong?